Carriage of S. aureus: A factor of bad prognosis in erysipelas ?;Portage de Staphylococcus aureus: Facteur de gravité de l'érysipèle?

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 1, 1996, Pages 12-15

  Bernard, P ^a   Risse, L ^a   Mounier, M ^a   Bonnetblanc, J M ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PRISTINAMYCIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYSIPELAS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CARRIER STATE; ERYSIPELAS; FEMALE; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; ROXITHROMYCIN; STAPHYLOCOCCUS AUREUS;

EID: 0029918689     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bernard P. Dermo-hypodermal bacterial infections: current concepts. Eur J Med 1992;1:97-104.
2. Bernard P, Bedane C, Mounier M, Denis F, Bonnetblanc JM. Dermohypodermites bactériennes de l'adulte : incidence et place de l'étiologie streptococcique. Ann Dermatol Venereol 1995;122: 495-500.
3. Ronnen M, Suster S, Schevach-Millet M, Modan M. Erysipelas: changing faces. Int J Dermatol 1985;24:169-72.
4. Jorup-Rönström C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis 1986;18:519-24.
5. Chartier C, Grosshans E. Erysipelas. Int J Dermatol 1990; 29:459-67.
6. Crickx B, Chevron F, Sigal-Nahum M et coll. Erysipèle : données épidémiologiques, cliniques et thérapeutiques (111 observations). Ann Dermatol Venereol 1991;118:11-6.
7. Bernard P, Denis F, Fayol J, Bonnetblanc JM. Increase in incidence of necrotizing fasciitis is not correlated to that of streptococcal bacteraemia or erysipelas. Dermatologica 1987;175:258-60.
8. Jörup-Ronström C, Britton C, Gavlevick C, Gunnarsson K, Redman AC. The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas. Infection 1984;12:390-4.
9. Hammar H, Wanger L. Erysipelas and necrotizing fasciitis. Br J Dermatol 1985;96:409-19.
10. Lorette G, Py F, Machet L, Vaillant L. Erysipèle : étude rétrospective de 100 cas. Med & Hyg 1990;48:764-8.
11. Bernard P, Plantin P, Roger H et al. Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study. Br J Dermatol 1992;127:155-9.
12. Bernard P, Risse L, Bonnetblanc JM. Traitement des dermohypodermites bactériennes par la pristinamycine : étude ouverte de 42 malades. Ann Dermatol Venereol 1996;123:16-20.
13. Bernard P, Bedane C, Mounier M, Denis F, Catanzano G, Bonnetblanc JM. Streptococcal cause of erysipelas and cellulitis in adults. Arch Dermatol 1989;125:779-82.
14. Noble WC, Valkenberg HA, Walters CHL. Carriage of Staphylococcus aureus in random samples of a normal population. J Hyg 1967;65:567-73.
15. Maxwell JG, Ford CR, Peterson DE, Mitchell CR. Long-term study of nasal staphylococci among hospital personnel. Am J Surg 1969;118:849-54.
16. Armstrong-Esther CA, Smith JE. Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann Hum Biol 1976;3:221-7.
17. Tuazon CU. Skin and skin structure infections in the patient at risk: carrier status of Staphylococcus aureus. Am J Med 1984; 76 (suppl. 5A): 166-71.
18. Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120:12-7.
19. Yu VL, Goetz A, Wagener M, Smith PB et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. N Engl J Med 1986;315:91-6.
20. Lannoux P, Penalba C, Legin C, Kivade M, Reveil JC. L'érysipèle. A propos de 118 observations. Med Mal Infect 1993;23: 908-12.
21. Seal DV, Kingston D. Streptococcal necrotizing fasciitis: development of an animal model to study its pathogenesis. Br J Exp Pathol 1988;69:813-31.